Clinical Trials Logo

Filter by:
NCT ID: NCT03645291 Completed - Clinical trials for Allergy to Arthropod Sting

Comparison of Skin Prick Testing and Intradermal Skin Test Result of Local and Imported Insect Allergen Extracts

Start date: June 20, 2018
Phase: N/A
Study type: Interventional

Comparison the results of skin prick testing and Intradermal skin test result of local and imported insect allergen extracts in patients with serious insect sting allergy reactions

NCT ID: NCT03645161 Completed - Clinical trials for Allergic Rhinitis Due to Animal Hair and Dander

Comparison Between Local and Imported Skin Prick Testing Result of Rat and Mouse Allergen Extracts

Start date: May 30, 2018
Phase: N/A
Study type: Interventional

In respiratory allergy patients, skin prick test results of local rat and mouse allergen extracts are not significant different from imported ones

NCT ID: NCT03641911 Completed - Pain, Acute Clinical Trials

Incidence of Inadequate Pain Treatment in Ventilated Critically Ill Surgical Patients

Start date: November 15, 2017
Phase:
Study type: Observational

In SICU, Siriraj hospital there were no protocols place for the management of pain. All decisions were made according the attending physicians. There were no information about incidence of inappropriate pain management in SICU due to lack of validated tool for assessment. To date, Thai-version of BPS and CPOT were validated, the incidence of inappropriate pain management in SICU, Siriraj hospital should be assessed.

NCT ID: NCT03640273 Completed - Quality of Life Clinical Trials

Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients

Start date: November 23, 2017
Phase: Phase 2
Study type: Interventional

1. To compare the effectiveness of Prapchompoothaweep crude drug at 3,000 mg per day and Loratadine 10 mg per day for treatment in Allergic Rhinitis patients. (Clinical Trial Phase II) 2. To evaluate the safety and adverse effect of Prapchompoothaweep crude drug at 3,000 mg and Loratadine 10 mg for Allergic Rhinitis patients.

NCT ID: NCT03638856 Completed - Infertility, Female Clinical Trials

Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy

Start date: September 30, 2018
Phase: N/A
Study type: Interventional

Research objective To compare effectiveness of oral Misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy Research hypothesis: Null hypothesis Effectiveness of oral misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy is not different from placebo Alternative hypothesis: : Oral Misoprostal for cervical priming in Premenopausal women underwent to diagnostic hysteroscopy is better than placebo

NCT ID: NCT03637556 Completed - Thalassemia Major Clinical Trials

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Start date: August 20, 2019
Phase: Phase 2
Study type: Interventional

This study is a multicenter, open-label, two-period crossover design that evaluates the safety, tolerability, pharmacokinetics and preliminary evidence of iron chelating activity of DST-0509 as compared to Jadenu and Exjade in transfusion-dependent thalassemia patients with transfusional iron overload, requiring iron chelation therapy and demonstrating an inadequate response to Jadenu or Exjade for greater than 3 months duration. Up to 36 patients will be evaluated (18 in each treatment arm), however, the balanced randomization may enroll fewer patients based on recruitment status.

NCT ID: NCT03636906 Completed - Clinical trials for Respiratory Syncytial Virus Infections

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Start date: April 8, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to provide critical information on the safety, reactogenicity and immunogenicity profile of the investigational recombinant chimpanzee adenovirus Type 155-vectored RSV (ChAd155-RSV) vaccine in infants likely to be unexposed to RSV and will assess a single lower dose and a higher two dose regimen, before moving to future studies. This study will also assess if there is a risk of 'vaccine-induced enhanced RSV disease' after vaccination of these infants with the ChAd155-RSV vaccine.

NCT ID: NCT03628651 Completed - Clinical trials for Hepatocellular Carcinoma

Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

Start date: April 2, 2018
Phase:
Study type: Observational

The primary objective of this study is to obtain de-identified, clinically-characterized whole blood specimens for use in developing and evaluating the performance of new biomarker assays for detection of hepatocellular carcinoma (HCC).

NCT ID: NCT03622710 Completed - Clinical trials for Spinal Cord Injuries

Effects of Walking Training on Different Surfaces on Walking Ability in Ambulatory Patients With Spinal Cord Injury

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

The study compares effects of 4-week walking training program on a walking track with difference surface [WTDS] and a firm ground on functional ability of ambulatory individuals with incomplete spinal cord injury [iSCI], using within- and between-group comparisons.

NCT ID: NCT03622593 Completed - Clinical trials for Diabetic Macular Edema

A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema

RHINE
Start date: October 9, 2018
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy, safety, and pharmacokinetics of faricimab administered at 8-week intervals or as specified in the protocol following treatment initiation, compared with aflibercept once every 8 weeks (Q8W), in participants with diabetic macular edema (DME).